Swiss Re introduces guidance for underwriters on repurposed longevity drugs

Share!

Reinsurance News - Aug 12, 2025

Swiss Re’s August 2025 Life Guide has introduced guidance for underwriters on how to assess life insurance applicants who show signs of using repurposed longevity drugs, an emerging trend among health-conscious individuals. The update provides new guidance on medications like metformin and rap...

Read Full Article

Recommended Articles

US cyber rates drop 32% at April 1, bespoke solutions surge amid ample reinsurance capacity: Gallagher Re

Posted: Apr 02, 2026

US cyber reinsurance rates fell around 32% during the April 1 renewals, impacted by a surge in exces...

Aon’s Reinsurance Solutions names Jukgrid Treesuttamas as Senior Advisor, Thailand

Posted: Apr 02, 2026

Aon’s Reinsurance Solutions, the reinsurance division of global broker Aon, has appointed Jukgrid Tr...

Markel Insurance appoints James Shankland as Head of Ocean Cargo, US

Posted: Apr 02, 2026

Markel, the insurance operations within Markel Group Inc., has announced the appointment of James Sh...